NCEL Stock Latest News
Company AnnouncementsNewcelX Files First-Half 2026 Results, Showing Wider Losses and Lower Cash1M ago6KNCEL
Company AnnouncementsNewcelX Lines Up $1.4 Million Private Placement to Advance Type 1 Diabetes Program2M ago6KNCEL
Company AnnouncementsNewcelX Prices $1.4 Million Premium Equity Financing to Advance Type 1 Diabetes Cell Therapy3M ago6KNCEL
Company AnnouncementsNewcelX Strengthens Diabetes Push With Appointment of Leading Transplant Pioneer Camillo Ricordi3M ago6KNCEL
Company AnnouncementsNewcelX Wins FDA Backing to Advance NCEL-101 Toward Type 1 Diabetes Trials4M ago6KNCEL
Company AnnouncementsNewcelX Shareholders Approve All Proposals at June 30 Annual Meeting4M ago6KNCEL
Company AnnouncementsNewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis4M ago6KNCEL
Company AnnouncementsNewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy5M ago6KNCEL
Company AnnouncementsNewcelX Posts 2025 Results and Bolsters Funding to Accelerate Type 1 Diabetes Program6M ago6KNCEL
Company AnnouncementsNewcelX Raises $1.35 Million in Premium-Priced Private Placement to Advance Type 1 Diabetes Program7M ago6KNCEL
Company AnnouncementsNewcelX Forms Eledon Alliance to Accelerate NCEL-101 Diabetes Program7M ago6KNCEL







